Pilot RCT of Computer-based Eye Movement Training

NCT07752563 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-07

No results posted yet for this study

Summary

The goal of this study is to learn whether NeuroEyeCoach, a computer-based eye movement training programme, can help stroke survivors with visual field loss. The study will also assess whether a larger clinical trial is feasible. The main questions it aims to answer are:

* Can stroke survivors be successfully recruited, randomised and followed up in a larger trial?
* Is NeuroEyeCoach acceptable and practical to use?
* Is there early evidence that NeuroEyeCoach improves vision-related functioning and wellbeing? Researchers will compare NeuroEyeCoach plus usual care with usual care alone.

Participants will:

* Be randomly assigned to receive NeuroEyeCoach plus usual care or usual care alone
* Complete six weeks of training if allocated to NeuroEyeCoach
* Complete questionnaires and tests of vision, daily activities, quality of life, confidence and wellbeing
* Take part in follow-up assessments over six months This pilot trial will include 60 stroke survivors living with visual field loss after stroke. Findings will be used to inform the design of a larger study.

Conditions

Interventions

DEVICE

NeuroEyeCoach eye movement training

computer based eye movement training for visual field loss in stroke

OTHER

Usual Care

Usual post-stroke care

Sponsors & Collaborators

  • National Health Service, United Kingdom

    collaborator OTHER_GOV
  • Glasgow Caledonian University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2027-07-31
Completion
2027-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07752563 on ClinicalTrials.gov